Lung Cancer Clinical Trials in Daegu, Gyeongsangbugdo [Kyongsangbuk-do]

A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection